Reading BCPC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track BCPC free→Reading BCPC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track BCPC free→NASDAQMaterialsSpecialty ChemicalsSnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, but the sector backdrop is a headwind. Earnings quality is neutral, and risk is moderate. Peer multiples imply a price about 54% below where it trades (it looks expensive on this basis); the read is rich, as it trades above peer multiples, and the longer horizon does not make that back through growth. Watching for guidance changes from BCPC and sector bellwethers like LIN, SHW, and ECL will be important, as these factors could significantly impact future performance. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $165.04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $165 the market pays 31× p/e — above the 20× p/e peer median but in line with its own 47× history. That premium reflects a durable franchise our peer-anchored $107 fair value understates; treat the 'expensive vs peers' read with medium confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 54% near-term growth, well above our forecast of about 7%. This describes what's priced in, not a forecast of the move.
Flags: expensive valuation, weak execution quality. Capped at elevated by the Crisis regime.
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Materials names rated strong grew net income 63% of the time over the next year (vs 54% for the rest of the cohort, n=1093).
Over the trailing year it converted 1.39x of net income into operating cash flow. Historically, Materials names rated neutral grew net income 52% of the time over the next year (vs 55% for the rest of the cohort, n=1297).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
Not enough signal yet.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.41 → $1.43 (+1.4% / 30d). 1 raised, 0 cut, 2 covering analysts.
0 upgrades, 0 downgrades / 30d. 67% of analysts rate Buy.
Market and fundamentals agree. Analysts are positioned bullishly on a fundamentally strong name.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$73.
How much price usually moves either way.
On a bad day, this stock has moved -$201.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $1,503.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Better margins show the company can set prices well and manage costs.
Confirms:Gross profit margins reported above 30% in Q2.
Disproves:Gross profit margins reported below 28% in Q2.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for BCPC yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition On April 30, 2026, Balchem Corporation reported earnings for the quarter ended March 31, 2026, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of th…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Specialty Chemicals.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
BCPC Balchem Corporation | Typical Show detailsSector percentile: 57 of 100 | expensive | moderate |
SHW Sherwin-Williams | Above typical Show detailsSector percentile: 71 of 100 | full | moderate |
ECL Ecolab | Above typical Show detailsSector percentile: 85 of 100 | expensive | moderate |
PPG PPG Industries | Above typical Show detailsSector percentile: 90 of 100 | fair | moderate |
LYB LyondellBasell | Typical Show detailsSector percentile: 54 of 100 | — | moderate |
Not investment advice. As of 2026-06-12.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Focus on achieving ongoing above-market revenue growth.
Continue efforts to improve operating income through cost management.
Aim to improve gross profit margins through operational efficiencies.
Why it matters: Positive revenue growth would signal a shift in the declining trend of the sector.
Confirms:Q2 revenue growth reported above 0% year over year.
Disproves:Q2 revenue growth remains negative year over year.
Why it matters: Higher operating income shows the company is managing costs well. This is important during tough times.
Confirms:Q2 operating income was higher than in the previous quarter.
Disproves:Q2 operating income was lower than in the previous quarter.
Why it matters: Higher operating income growth shows better cost management. This can help make more money.
Confirms:Operating income growth reported at 15% or higher year over year.
Disproves:Operating income growth is below 5% compared to last year.
Why it matters: If the sector shifts from headwind to neutral, it could support Balchem's growth. This change may help overall market sentiment.
Confirms one read:Sector performance gets better to neutral or higher.
Confirms the other:Sector performance gets worse and stays in headwind status.